Benson, A. B., Wainberg, Z. A., Hecht, J. R., Vyushkov, D., Dong, H., Bendell, J., & Kudrik, F. (2017). A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma. Oncologist.

Benson, Al B., Zev A. Wainberg, J. Randolph Hecht, Dmitry Vyushkov, Hua Dong, Johanna Bendell, och Fred Kudrik. "A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination With Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma." Oncologist 2017.

Benson, Al B., et al. "A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination With Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma." Oncologist 2017.